Suscribirse

Relationship of Ethnic Origin, Gender, and Age to Blood Creatine Kinase Levels - 12/08/11

Doi : 10.1016/j.amjmed.2008.08.033 
Ryan C. Neal, MD a, , Keith C. Ferdinand, MD b, Joseph Yčas, PhD c, Elinor Miller, MD c
a Baylor College of Medicine, Houston, Tex 
b Association of Black Cardiologists, Inc, Atlanta, Ga 
c AstraZeneca LP, Wilmington, Del 

Requests for reprints should be addressed to Ryan C. Neal, MD, Diagnostic Clinic of Houston, 1200 Binz Street, Suite 700, Houston, TX 77030

Abstract

Background

Creatine kinase is expressed at high levels in muscle, where it plays a central role in energy metabolism. Highly elevated creatine kinase levels in blood may indicate muscle trauma or disease. However, it is known that baseline creatine kinase levels are higher in African Americans than in whites and that they are higher in men than in women. This analysis explores the relationship of ethnic origin, gender, and age to baseline blood creatine kinase levels in a large group of adults with hypercholesterolemia.

Methods

Data from the screening phases of 4 North American trials of statins, which included large numbers of specific racial/ethnic populations, were combined for analysis. The pooled population (N=11,346) included 2760 African Americans, 3301 whites, 2930 Hispanics, and 2355 South Asians.

Results

Creatine kinase levels varied according to ethnic origin, gender, and age. African American participants had higher median creatine kinase levels than did individuals of the 3 other ethnicities. Within each ethnic group, men had higher median creatine kinase levels than women: African Americans, 135 versus 73 U/L; whites, 64 versus 42 U/L; Hispanics, 69 versus 48 U/L; and South Asians, 74 versus 50 U/L. An age-dependent decrease in creatine kinase levels was noted among men, but no such trend was seen among women. The median creatine kinase levels for younger African American men exceeded the standard upper limit of normal.

Conclusion

Physicians should use caution when interpreting creatine kinase levels that seem elevated, particularly when treating African American patients and younger men.

El texto completo de este artículo está disponible en PDF.

Keywords : Age, Creatine kinase, Gender, Race, Variation


Esquema


 Funding: The ARIES, IRIS, SOLAR, and STARSHIP studies, as well as this analysis of pooled screening data, were funded by AstraZeneca LP, Wilmington, Delaware.
 Conflict of Interest: Dr Neal is an active member of the Speakers' Bureau and consultant for AstraZeneca, with honoraria exceeding $50,000. Dr Ferdinand is an AstraZeneca consultant and member of the Speakers' Bureau, with honoraria totaling $50,000 for the past 3 years. Drs Yčas and Miller are employees of AstraZeneca.
 Authorship: All authors had full access to the data and played a role in writing this article.


© 2009  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 122 - N° 1

P. 73-78 - janvier 2009 Regresar al número
Artículo precedente Artículo precedente
  • The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study
  • Mohamed G. Atta, Kesha Baptiste-Roberts, Frederick L. Brancati, Tiffany L. Gary
| Artículo siguiente Artículo siguiente
  • Electrocardiography Screening for Cardiotoxicity after Modified Vaccinia Ankara Vaccination
  • Junko Sano, Bernard R. Chaitman, Jason Swindle, Sharon E. Frey

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.